Patents by Inventor Jack E. Ulstad

Jack E. Ulstad has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8721636
    Abstract: The invention provides apparatus and methods for mapping conduction pathways and creating lesions in the heart wall for the treatment of atrial fibrillation. The apparatus may include at least one epicardial ablation probe having a plurality of electrodes for creating a lesion. The apparatus and method facilitate the formation of a lesion which electrically isolates the pulmonary veins from the surrounding myocardium.
    Type: Grant
    Filed: May 13, 2005
    Date of Patent: May 13, 2014
    Assignee: St. Jude Medical, Atrial Fibrillation Division, Inc.
    Inventors: Matthias Vaska, Banjamin Pless, David A. Gallup, Jack E. Ulstad, Jr., Scott C. Anderson, Roxanne L. Richman
  • Publication number: 20120271334
    Abstract: A control system alters one or more characteristics of an ablating element to ablate tissue. In one aspect, the control system delivers energy nearer to the surface of the tissue by changing the frequency or power. In another aspect, the ablating element delivers focused ultrasound which is focused in at least one dimension. The ablating device may also have a number of ablating elements with different characteristics such as focal length.
    Type: Application
    Filed: July 2, 2012
    Publication date: October 25, 2012
    Inventors: Benjamin Pless, Scott C. Anderson, Jonathan L. Podmore, Matthias Vaska, John E. Crowe, Roxanne L. Richman, Timothy Ciciarelli, David A. Gallup, Jack E. Ulstad, JR.
  • Patent number: 8211096
    Abstract: A control system alters one or more characteristics of an ablating element to ablate tissue. In one aspect, the control system delivers energy nearer to the surface of the tissue by changing the frequency or power. In another aspect, the ablating element delivers focused ultrasound which is focused in at least one dimension. The ablating device may also have a number of ablating elements with different characteristics such as focal length. The invention provides an ablation apparatus and methods for ablating tissue wherein the ablation apparatus may have ablating elements that are moveable relative to the tissue to be ablated without the need to relocate the apparatus as a whole.
    Type: Grant
    Filed: August 9, 2007
    Date of Patent: July 3, 2012
    Assignee: St. Jude Medical, Atrial Fibrillation Division, Inc.
    Inventors: Benjamin Pless, Scott C. Anderson, Jonathan L. Podmore, Matthias Vaska, John E. Crowe, Roxanne L. Richman, Timothy Ciciarelli, David A. Gallup, Jack E. Ulstad, Jr.
  • Patent number: 7674257
    Abstract: A control system alters one or more characteristics of an ablating element to ablate tissue. In one aspect, the control system delivers energy nearer to the surface of the tissue by changing the frequency or power. In another aspect, the ablating element delivers focused ultrasound which is focused in at least one dimension. The ablating device may also have a number of ablating elements with different characteristics such as focal length.
    Type: Grant
    Filed: June 28, 2004
    Date of Patent: March 9, 2010
    Assignee: St. Jude Medical, Atrial Fibrillation Division, Inc.
    Inventors: Benjamin Pless, Scott C. Anderson, Jonathan L. Podmore, Matthias Vaska, John E. Crowe, Roxanne L. Richman, Timothy Ciciarelli, David A. Gallup, Jack E. Ulstad, Jr.
  • Patent number: 6949095
    Abstract: The invention provides apparatus and methods for mapping conduction pathways and creating lesions in the heart wall for the treatment of atrial fibrillation. The apparatus may include at least one epicardial ablation probe having a plurality of electrodes for creating a lesion. The apparatus and method facilitate the formation of a lesion which electrically isolates the pulmonary veins from the surrounding myocardium.
    Type: Grant
    Filed: August 30, 2002
    Date of Patent: September 27, 2005
    Assignee: Epicor Medical, Inc.
    Inventors: Matthias Vaska, Benjamin Pless, David A. Gallup, Jack E. Ulstad, Jr., Scott C. Anderson, Roxanne L. Richman
  • Patent number: 6929010
    Abstract: The invention provides apparatus and methods for mapping conduction pathways and creating lesions in the heart wall for the treatment of atrial fibrillation. The apparatus may include at least one epicardial ablation probe having a plurality of electrodes for creating a lesion. The apparatus and method facilitate the formation of a lesion which electrically isolates the pulmonary veins from the surrounding myocardium.
    Type: Grant
    Filed: August 30, 2002
    Date of Patent: August 16, 2005
    Assignee: Epicor Medical, Inc.
    Inventors: Matthias Vaska, Banjamin Pless, David A. Gallup, Jack E. Ulstad, Jr., Scott C. Anderson, Roxanne L. Richman
  • Publication number: 20040260278
    Abstract: The invention provides apparatus and methods for ablating tissue and is particularly useful for creating lesions in the heart wall for the treatment of atrial fibrillation. The apparatus has a suction well which is adhered to the tissue to be ablated. The ablating element is surrounded by the suction well. A fluid is delivered to the ablating element to conduct RF energy to the tissue and/or to cool the tissue. The device is preferably formed with a number of cells with each cell having a suction well and at least one ablating element. The device also preferably has a locking mechanism for locking one part of the device to another part of the device to form a closed loop for ablating around structures such as the pulmonary veins.
    Type: Application
    Filed: April 12, 2004
    Publication date: December 23, 2004
    Inventors: Scott C. Anderson, Jonathan L. Podmore, Roxanne L. Richman, Matthias Vaska, David A. Gallup, John E. Crowe, Jack E. Ulstad, Benjamin Pless
  • Patent number: 6805129
    Abstract: A control system alters one or more characteristics of an ablating element to ablate tissue. In one aspect, the control system delivers energy nearer to the surface of the tissue by changing the frequency or power. In another aspect, the ablating element delivers focused ultrasound which is focused in at least one dimension. The ablating device may also have a number of ablating elements with different characteristics such as focal length.
    Type: Grant
    Filed: October 27, 2000
    Date of Patent: October 19, 2004
    Assignee: Epicor Medical, inc.
    Inventors: Benjamin Pless, Scott C. Anderson, Jonathan L. Podmore, Matthias Vaska, John E. Crowe, Roxanne L. Richman, Timothy Ciciarelli, David A. Gallup, Jack E. Ulstad, Jr.
  • Patent number: 6805128
    Abstract: A control system alters one or more characteristics of an ablating element to ablate tissue. In one aspect, the control system delivers energy nearer to the surface of the tissue by changing the frequency or power. In another aspect, the ablating element delivers focused ultrasound which is focused in at least one dimension. The ablating device may also have a number of ablating elements with different characteristics such as focal length.
    Type: Grant
    Filed: July 12, 2000
    Date of Patent: October 19, 2004
    Assignee: Epicor Medical, Inc.
    Inventors: Benjamin Pless, Scott C. Anderson, Jonathan L. Podmore, Matthias Vaska, John E. Crowe, Roxanne L. Richman, Timothy Ciciarelli, David A. Gallup, Jack E. Ulstad, Jr.
  • Patent number: 6645202
    Abstract: A control system alters one or more characteristics of an ablating element to ablate tissue. In one aspect, the control system delivers energy nearer to the surface of the tissue by changing the frequency or power. In another aspect, the ablating element delivers focused ultrasound which is focused in at least one dimension. The ablating device may also have a number of ablating elements with different characteristics such as focal length.
    Type: Grant
    Filed: October 27, 2000
    Date of Patent: November 11, 2003
    Assignee: Epicor Medical, Inc.
    Inventors: Benjamin Pless, Scott C. Anderson, Jonathan L. Podmore, Matthias Vaska, John E. Crowe, Roxanne L. Richman, Timothy Ciciarelli, David A. Gallup, Jack E. Ulstad, Jr.
  • Publication number: 20030079753
    Abstract: The invention provides apparatus and methods for mapping conduction pathways and creating lesions in the heart wall for the treatment of atrial fibrillation. The apparatus may include at least one epicardial ablation probe having a plurality of electrodes for creating a lesion. The apparatus and method facilitate the formation of a lesion which electrically isolates the pulmonary veins from the surrounding myocardium.
    Type: Application
    Filed: August 30, 2002
    Publication date: May 1, 2003
    Applicant: EPICOR, INC.
    Inventors: Matthias Vaska, Benjamin Pless, David A. Gallup, Jack E. Ulstad, Scott C. Anderson, Roxanne L. Richman
  • Publication number: 20030069577
    Abstract: The invention provides apparatus and methods for mapping conduction pathways and creating lesions in the heart wall for the treatment of atrial fibrillation. The apparatus may include at least one epicardial ablation probe having a plurality of electrodes for creating a lesion. The apparatus and method facilitate the formation of a lesion which electrically isolates the pulmonary veins from the surrounding myocardium.
    Type: Application
    Filed: August 30, 2002
    Publication date: April 10, 2003
    Applicant: EPICOR, INC.
    Inventors: Matthias Vaska, Benjamin Pless, David A. Gallup, Jack E. Ulstad, Scott C. Anderson, Roxanne L. Richman
  • Publication number: 20030028187
    Abstract: The invention provides apparatus and methods for mapping conduction pathways and creating lesions in the heart wall for the treatment of atrial fibrillation. The apparatus may include at least one epicardial ablation probe having a plurality of electrodes for creating a lesion. The apparatus and method facilitate the formation of a lesion which electrically isolates the pulmonary veins from the surrounding myocardium.
    Type: Application
    Filed: June 12, 2002
    Publication date: February 6, 2003
    Applicant: Epicor, Inc.
    Inventors: Matthias Vaska, Benjamin Pless, David A. Gallup, Jack E. Ulstad, Scott C. Anderson, Roxanne L. Richman
  • Patent number: 6484727
    Abstract: The invention provides apparatus and methods for mapping conduction pathways and creating lesions in the heart wall for the treatment of atrial fibrillation. The apparatus may include at least one epicardial ablation probe having a plurality of electrodes for creating a lesion. The apparatus and method facilitate the formation of a lesion which electrically isolates the pulmonary veins from the surrounding myocardium.
    Type: Grant
    Filed: November 15, 1999
    Date of Patent: November 26, 2002
    Assignee: Epicor, Inc.
    Inventors: Matthias Vaska, Banjamin Pless, David A. Gallup, Jack E. Ulstad, Jr., Scott C. Anderson, Roxanne L. Richman
  • Patent number: 6474340
    Abstract: The invention provides apparatus and methods for mapping conduction pathways and creating lesions in the heart wall for the treatment of atrial fibrillation. The apparatus may include at least one epicardial ablation probe having a plurality of electrodes for creating a lesion. The apparatus and method facilitate the formation of a lesion which electrically isolates the pulmonary veins from the surrounding myocardium.
    Type: Grant
    Filed: November 15, 1999
    Date of Patent: November 5, 2002
    Assignee: Epicor, Inc.
    Inventors: Matthias Vaska, Benjamin Pless, David A. Gallup, Jack E. Ulstad, Jr., Scott C. Anderson, Roxanne L. Richman
  • Publication number: 20020128639
    Abstract: A control system alters one or more characteristics of an ablating element to ablate tissue. In one aspect, the control system delivers energy nearer to the surface of the tissue by changing the frequency or power. In another aspect, the ablating element delivers focused ultrasound which is focused in at least one dimension. The ablating device may also have a number of ablating elements with different characteristics such as focal length.
    Type: Application
    Filed: December 21, 2001
    Publication date: September 12, 2002
    Applicant: EPICOR, INC., a Delaware Corporation
    Inventors: Benjamin Pless, Scott C. Anderson, Jonathan L. Podmore, Matthias Vaska, John E. Crowe, Roxanne L. Richman, Timothy Ciciarelli, David A. Gallup, Jack E. Ulstad
  • Patent number: 6314962
    Abstract: The invention provides apparatus and methods for mapping conduction pathways and creating lesions in the heart wall for the treatment of atrial fibrillation. The apparatus may include at least one epicardial ablation probe having a plurality of electrodes for creating a lesion. The apparatus and method facilitate the formation of a lesion which electrically isolates the pulmonary veins from the surrounding myocardium.
    Type: Grant
    Filed: November 15, 1999
    Date of Patent: November 13, 2001
    Assignee: Epicor, Inc.
    Inventors: Matthias Vaska, Benjamin Pless, David A. Gallup, Jack E. Ulstad, Jr., Scott C. Anderson, Roxanne L. Richman
  • Patent number: 6314963
    Abstract: The invention provides apparatus and methods for mapping conduction pathways and creating lesions in the heart wall for the treatment of atrial fibrillation. The apparatus may include at least one epicardial ablation probe having a plurality of electrodes for creating a lesion. The apparatus and method facilitate the formation of a lesion which electrically isolates the pulmonary veins from the surrounding myocardium.
    Type: Grant
    Filed: November 15, 1999
    Date of Patent: November 13, 2001
    Assignee: Epicor, Inc.
    Inventors: Matthias Vaska, Banjamin Pless, David A. Gallup, Jack E. Ulstad, Jr., Scott C. Anderson, Roxanne L. Richman
  • Patent number: 6311692
    Abstract: The invention provides apparatus and methods for mapping conduction pathways and creating lesions in the heart wall for the treatment of atrial fibrillation. The apparatus may include at least one epicardial ablation probe having a plurality of electrodes for creating a lesion. The apparatus and method facilitate the formation of a lesion which electrically isolates the pulmonary veins from the surrounding myocardium.
    Type: Grant
    Filed: July 19, 1999
    Date of Patent: November 6, 2001
    Assignee: Epicor, Inc.
    Inventors: Matthias Vaska, Benjamin Pless, David A. Gallup, Jack E. Ulstad, Jr., Scott C. Anderson, Roxanne L. Richman
  • Patent number: 5474546
    Abstract: A dripless cannula system usable with a syringe or other fluid container in a fluid sampling procedure and operable to minimize retention of residual fluids at a sampling site following the sampling procedure. In the preferred embodiment, a vacuum chamber operatively connected to a blunt cannula of the dripless cannula system is operative upon withdrawal of the cannula from the sampling site to draw residual fluids at the site into the vacuum chamber for subsequent disposal. The dripless cannula system of the present invention is a simple, effective apparatus for minimizing the presence of residual fluids at a sampling site following a sampling procedure.
    Type: Grant
    Filed: May 9, 1994
    Date of Patent: December 12, 1995
    Assignee: Abbott Laboratories
    Inventors: William M. Ambrisco, Lauretta A. Iwamasa, Jack E. Ulstad